Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Toward a mechanism-based in vitro safety test for pertussis toxin.

Vaessen SF, Bruysters MW, Vandebriel RJ, Verkoeijen S, Bos R, Krul CA, Akkermans AM.

Hum Vaccin Immunother. 2014 Feb 19;10(5). [Epub ahead of print] Review.

PMID:
24553455
[PubMed - as supplied by publisher]
2.
3.

The concept of pertussis as a toxin-mediated disease.

Pittman M.

Pediatr Infect Dis. 1984 Sep-Oct;3(5):467-86. Review.

PMID:
6093069
[PubMed - indexed for MEDLINE]
4.

Transferability of dermal temperature histamine sensitization test for estimation of pertussis toxin activity in vaccines.

Gaines-Das R, Ochiai M, Douglas-Bardsley A, Asokanathan C, Horiuchi Y, Rigsby P, Corbel MJ, Xing DK.

Hum Vaccin. 2009 Mar;5(3):166-71. Epub 2009 Mar 15.

PMID:
18758243
[PubMed - indexed for MEDLINE]
Free Article
5.

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.

Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A; Stage III Working Group.

Pediatrics. 2001 Nov;108(5):E81.

PMID:
11694665
[PubMed - indexed for MEDLINE]
6.

Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines.

Xing D, Maes A, Behr-Gross ME, Costanzo A, Daas A, Buchheit KH.

Pharmeur Bio Sci Notes. 2010 Apr;2010(1):51-63.

PMID:
20223190
[PubMed - indexed for MEDLINE]
7.

Characterization of the carbohydrate binding and ADP-ribosyltransferase activities of chemically detoxified pertussis toxins.

Oh H, Kim BG, Nam KT, Hong SH, Ahn DH, Choi GS, Kim H, Hong JT, Ahn BY.

Vaccine. 2013 Jun 24;31(29):2988-93. doi: 10.1016/j.vaccine.2013.04.060. Epub 2013 May 9.

PMID:
23664992
[PubMed - indexed for MEDLINE]
8.

The cAMP assay: a functional in vitro alternative to the in vivo Histamine Sensitization test.

Hoonakker ME, Ruiterkamp N, Hendriksen CF.

Vaccine. 2010 Feb 3;28(5):1347-52. doi: 10.1016/j.vaccine.2009.11.009. Epub 2009 Nov 24.

PMID:
19941995
[PubMed - indexed for MEDLINE]
9.

Evaluation of two serological methods for potency testing of whole cell pertussis vaccines.

von Hunolstein C, Gomez Miguel MJ, Pezzella C, Scopetti F, Behr-Gross ME, Halder M, Hoffmann S, Levels L, van der Gun J, Hendriksen C.

Pharmeuropa Bio. 2008 Dec;2008(1):7-18.

PMID:
19220977
[PubMed - indexed for MEDLINE]
10.

Characterization of pertussis toxin analogs containing mutations in B-oligomer subunits.

Loosmore S, Zealey G, Cockle S, Boux H, Chong P, Yacoob R, Klein M.

Infect Immun. 1993 Jun;61(6):2316-24.

PMID:
8500874
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Developments in reduction and replacement of in vivo toxicity and potency tests for pertussis vaccines.

Xing D, Canthaboo C, Douglas-Bardsley A, Yuen CT, Prior S, Liu Y, Corbel M.

Dev Biol (Basel). 2002;111:57-68.

PMID:
12678225
[PubMed - indexed for MEDLINE]
12.

Construction of minitransposons for constitutive and inducible expression of pertussis toxin in bvg-negative Bordetella bronchiseptica.

Walker MJ, Rohde M, Wehland J, Timmis KN.

Infect Immun. 1991 Nov;59(11):4238-48.

PMID:
1682257
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

A sensitive method for measuring neutralizing antibodies to Bordetella pertussis toxin: optimized ADP-ribosylation of transducin.

Magnusson R, Larsson U, Bartfai T, Askelöf P.

Biologicals. 1991 Jan;19(1):9-15.

PMID:
2049177
[PubMed - indexed for MEDLINE]
14.

Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough.

Nencioni L, Pizza M, Bugnoli M, De Magistris T, Di Tommaso A, Giovannoni F, Manetti R, Marsili I, Matteucci G, Nucci D, et al.

Infect Immun. 1990 May;58(5):1308-15.

PMID:
2323818
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Acute ethanol-induced adenosine diphosphate ribosylation regulates the functional activity of rat striatal pertussis toxin-sensitive g proteins.

Dar MS, Meng ZH.

Alcohol Clin Exp Res. 2004 Sep;28(9):1299-307.

PMID:
15365299
[PubMed - indexed for MEDLINE]
16.

Comparative study of different sources of pertussis toxin (PT) as coating antigens in IgG anti-PT enzyme-linked immunosorbent assays.

Kapasi A, Meade BD, Plikaytis B, Pawloski L, Martin MD, Yoder S, Rock MT, Coddens S, Haezebroeck V, Fievet-Groyne F, Bixler G, Jones C, Hildreth S, Edwards KM, Messonnier NE, Tondella ML.

Clin Vaccine Immunol. 2012 Jan;19(1):64-72. doi: 10.1128/CVI.05460-11. Epub 2011 Nov 23.

PMID:
22116688
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.

Pichichero ME, Deloria MA, Rennels MB, Anderson EL, Edwards KM, Decker MD, Englund JA, Steinhoff MC, Deforest A, Meade BD.

Pediatrics. 1997 Nov;100(5):772-88.

PMID:
9346976
[PubMed - indexed for MEDLINE]
18.

Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infection.

Alonso S, Pethe K, Mielcarek N, Raze D, Locht C.

Infect Immun. 2001 Oct;69(10):6038-43.

PMID:
11553541
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Acellular pertussis vaccine composed of genetically inactivated pertussis toxin.

Peppoloni S, Pizza M, De Magistris MT, Bartoloni A, Rappuoli R.

Physiol Chem Phys Med NMR. 1995;27(4):355-61. Review.

PMID:
8768791
[PubMed - indexed for MEDLINE]
20.

An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants.

Lee CY, Thipphawong J, Huang LM, Lee PI, Chiu HH, Lin W, Debois H, Harrison D, Xie F, Barreto L.

Pediatrics. 1999 Jan;103(1):25-30.

PMID:
9917435
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk